• 首页
  • 创刊词
  • 期刊介绍
    • 杂志简介
    • 编委会
    • 编辑部
  • 过刊浏览
  • 杂志订阅
    • 订阅须知
    • 在线订阅
  • 在线投稿
    • 投稿指南
    • 年度选题
    • 在线投稿
  • 下载中心
  • 学术交流
    • 研究论坛
    • 学术沙龙
    • 编委会会议
  • 登录
    • 作者登录
    • 审稿登录
    • 编辑登录
    • 读者登录
引用本文:赵娜娜, 叶子平, 孙利华.国际参考价格在药品价格监测中的应用研究——以加拿大为例[J].中国卫生政策研究,2017,10(2):16-20
国际参考价格在药品价格监测中的应用研究——以加拿大为例
投稿时间:2016-11-14  修订日期:2016-12-19  PDF全文浏览  HTML全文浏览
赵娜娜, 叶子平, 孙利华
沈阳药科大学工商管理学院 辽宁沈阳 110016
摘要:目的:分析总结加拿大基于国际参考价格的药品价格监测模式,以期为完善我国药品价格监测体系提供参考。方法:通过政策分析和文献研究,系统梳理加拿大采用国际参考价格进行药价监测的具体做法。结果:对于引入期的新药,加拿大采用国际中位价格比较测试、最高国际价格比较测试、国内治疗类别比较测试和国际治疗类别比较测试四种方法监测其药品价格;对于已上市的药品,加拿大主要通过计算国际价格比值,进而进行双边比较和多边比较来监测其药品价格。目前加拿大已实现对药品价格的有效监测,即引入期的新药价格符合《过高价格指南》;已上市的专利药价格低于国际价格水平;非专利药价格水平与国际水平的价格差异已逐步减小。结论:建议我国借鉴加拿大药价监测经验,增加对药品价格监测的立法,分类确定监测品种,并探索建立以国际参考价格为警兆指标的药价监测预警机制。
关键词:国际参考价格  药品价格监测  加拿大
Study on the application of International Reference Price in drug price monitoring: A case study of Canada
ZHAO Na-na, YE Zi-ping, SUN Li-hua
Business Administration College, Shenyang Pharmaceutical University, Shenyang Liaoning 110016, China
Abstract:Objective:This paper aims to analyze the monitoring model of Canadian drug price monitoring model based on the international reference price, and make reference for China. Methods:Through policy analysis and literature research, the system combs the specific Canadian practices of using the international reference prices for the drug price monitoring. Results:For the introduction of new drug prices, Canada uses the international median price comparison test, the highest international price comparison test, the treatment category comparison test and the international treatment category comparison test. For the listed drugs, Canada calculates the international price ratio, and then carries out bilateral comparisons and multilateral comparisons to monitor the prices of drugs already on the market. At present, Canada has achieved effective monitoring of drug prices, that is to say, the introduction of new drug prices complies with the 《Excessive Price Guide》; the patented drugs prices are lower than the designed international price; the price difference between the generic drug and the international level has gradually reduced. Conclusions:The Canadian experience is worth learning, and China should add legislative about drug price monitoring, learn from this experience to identify and monitor the varieties and establish the price monitoring and early warning mechanism with the international reference price as the warning indicator.
Key words:International Reference Price  Drug price monitoring  Canada
摘要点击次数: 2449    全文下载次数: 9
版权所有:《中国卫生政策研究》编辑部
您是本站第62348740位读者 今日访问5267次
京ICP备10218182号-6

京公网安备 11010502037852号